In 2025, HJ Jeon and team from South Korea studied 661,122 people using the Korean National Health Insurance Service data. They compared 4,664 patients who had their gallbladder removed to 13,992 matched individuals who didn’t, over 5.35 years, to check for metabolic dysfunction-associated steatotic liver disease (MASLD), a fatty liver condition tied to obesity or diabetes.